Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports

AimsThe use of subcutaneous infusion ports has become standard practice to provide a long-term venous access in oncological patients. The aim of this retrospective study was to assess the different complications of infusion ports in our population and to identify predisposing factors.Patients and methodsWe reviewed the medical records of 437 patients who were followed at the Oncology/Haematology Department of our hospital. Of these patients, there were 370 (84.4%) with solid tumours and 58 (13.2%) with haematological disease. The position of the catheter tip was evaluated by reviewing the available chest radiographs or phlebographies.Main resultsAnalysis of the records showed that 346 patients (79.17%) had no complications. The most common complications after implantation were thrombosis (8.46%), catheter dysfunction (4.8%) and infections (4.4%). Univariate and multivariate analysis showed that catheter tip positioning was the most important predisposing risk factor for thrombosis. Catheter tips positioned in the brachiocephalic vein or in the cranial part of the superior vena cava were associated with a high risk of thrombosis. Other significant risk factors were gender and initial diagnosis. Female patients and patients with lung cancer also had an elevated risk of developing a thrombosis.ConclusionsCompared to other reports, we noted a higher rate of thrombosis and port dysfunction. Since catheter tip position was a predisposing factor for developing a thrombosis, correct catheter position has to be ensured during placement. Prophylactic antithrombotic treatment might be beneficial in the event of failure to position the catheter correctly.

[1]  C. Barrios,et al.  Evaluation of an implantable venous access system in a general oncology population. , 1992, Oncology.

[2]  R. Rosell,et al.  Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin) , 1996, Thrombosis and Haemostasis.

[3]  J. Lokich,et al.  Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy , 1983, Cancer.

[4]  P. Benotti,et al.  Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. , 1990, Annals of internal medicine.

[5]  Z. Barley,et al.  Tunneled catheter thrombosis: factors related to incidence. , 1990, Oncology nursing forum.

[6]  M. Monreal,et al.  Pulmonary Embolism in Patients with Upper Extremity DVT Associated to Venous Central Lines - A Prospective Study , 1994, Thrombosis and Haemostasis.

[7]  M. De Cicco,et al.  Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. , 1995, Thrombosis research.

[8]  C. Marsault,et al.  Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports , 1993, Cancer.

[9]  J. Doppman,et al.  Venographic surveillance of tunneled venous access devices in adult oncology patients , 1995, Annals of Surgical Oncology.

[10]  J. P. Puig-La Calle,et al.  Totally implanted device for long‐term intravenous chemotherapy: Experience in 123 adult patients with solid neoplasms , 1996, Journal of surgical oncology.

[11]  S. Laporte,et al.  Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. , 2003, Haematologica.

[12]  J. Moake,et al.  Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. , 1985, Oncology.

[13]  Stone Mh,et al.  Tunneled catheter thrombosis: factors related to incidence. , 1990 .

[14]  M. Carlier,et al.  Les thromboses veineuses sur cathéter central en cancérologie , 1996 .

[15]  H. Kock,et al.  Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems , 1998, World Journal of Surgery.

[16]  J. Schlangen,et al.  A rare complication of implanted central-venous access devices: catheter fracture and embolization , 1995, Supportive Care in Cancer.

[17]  M. Gent,et al.  An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. , 2003, Thrombosis research.

[18]  M. Monreal,et al.  Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. , 1991, Chest.

[19]  J. Niederhuber,et al.  Totally implanted venous and arterial access system to replace external catheters in cancer treatment. , 1982, Surgery.

[20]  D. Coit,et al.  Subcutaneously implanted central venous access devices in cancer patients , 1997, Cancer.

[21]  I. B. Rinkes,et al.  No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients , 2000, Bone Marrow Transplantation.

[22]  B. Eastridge,et al.  Complications of indwelling venous access devices in cancer patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Marcus,et al.  Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies , 1998, British journal of haematology.

[24]  J. C. Pector Vascular access problems , 1997, Supportive Care in Cancer.

[25]  M. De Cicco,et al.  Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. , 1997, Thrombosis research.

[26]  F. Orsi,et al.  Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  L. G. Ortega,et al.  Thrombosis: the major Hickman catheter complication in patients with solid tumor. , 1989, Chest.